公开(公告)号：WO2010030359A3

公开(公告)日：2010-05-27

申请号：PCT/US2009005082

申请日：2009-09-10

Applicant: ENANTA PHARJMACEUTICALS INC ,  ABBOTT LAB ,  KU YIYIN ,  MCDANIEL KEITH F ,  CHEN HUI-JU ,  SHANLEY JASON P ,  KEMPF DALE J ,  GRAMPOVNIK DAVID J ,  SUN YING ,  LIU DONG ,  GAI YONGHUA ,  OR YAT SUN ,  WAGAW SABLE H ,  ENGSTROM KEN ,  GRIEME TIM ,  SHEIKH AHMAD ,  MEI JIANZHANG

Inventor： KU YIYIN ,  MCDANIEL KEITH F ,  CHEN HUI-JU ,  SHANLEY JASON P ,  KEMPF DALE J ,  GRAMPOVNIK DAVID J ,  SUN YING ,  LIU DONG ,  GAI YONGHUA ,  OR YAT SUN ,  WAGAW SABLE H ,  ENGSTROM KEN ,  GRIEME TIM ,  SHEIKH AHMAD ,  MEI JIANZHANG

IPC: A61K38/00 ,  A61K38/12

CPC classification number: C07K1/113 ,  C07D487/04

Abstract: The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.

Abstract translation: 本发明涉及新的大环化合物及其使用方法。 本发明还涉及包含本发明化合物或其药学上可接受的盐，酯或前药与药学上可接受的载体或赋形剂组合的药物组合物。

公开(公告)号：WO2010030359A8

公开(公告)日：2011-05-12

申请号：PCT/US2009005082

申请日：2009-09-10

Applicant: ENANTA PHARM INC ,  ABBOTT LAB ,  KU YIYIN ,  MCDANIEL KEITH F ,  CHEN HUI-JU ,  SHANLEY JASON P ,  KEMPF DALE J ,  GRAMPOVNIK DAVID J ,  SUN YING ,  LIU DONG ,  GAI YONGHUA ,  OR YAT SUN ,  WAGAW SABLE H ,  ENGSTROM KEN ,  GRIEME TIM ,  SHEIKH AHMAD ,  MEI JIANZHANG

Inventor： KU YIYIN ,  MCDANIEL KEITH F ,  CHEN HUI-JU ,  SHANLEY JASON P ,  KEMPF DALE J ,  GRAMPOVNIK DAVID J ,  SUN YING ,  LIU DONG ,  GAI YONGHUA ,  OR YAT SUN ,  WAGAW SABLE H ,  ENGSTROM KEN ,  GRIEME TIM ,  SHEIKH AHMAD ,  MEI JIANZHANG

IPC: A61K38/00 ,  A61K38/12

CPC classification number: C07K1/113 ,  C07D487/04

Abstract: The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.

Abstract translation: 本发明涉及新的大环化合物及其使用方法。 本发明还涉及包含本发明化合物或其药学上可接受的盐，酯或前药与药学上可接受的载体或赋形剂组合的药物组合物。

公开(公告)号：WO2010030359A2

公开(公告)日：2010-03-18

申请号：PCT/US2009/005082

申请日：2009-09-10

Applicant: ENANTA PHARJMACEUTICALS, INC. ,  ABBOTT LABORATORIES ,  KU, Yiyin ,  MCDANIEL, Keith, F. ,  CHEN, Hui-ju ,  SHANLEY, Jason, P. ,  KEMPF, Dale, J. ,  GRAMPOVNIK, David, J. ,  SUN, Ying ,  LIU, Dong ,  GAI, Yonghua ,  OR, Yat, Sun ,  WAGAW, Sable, H. ,  ENGSTROM, Ken ,  GRIEME, Tim ,  SHEIKH, Ahmad ,  MEI, Jianzhang

Inventor： KU, Yiyin ,  MCDANIEL, Keith, F. ,  CHEN, Hui-ju ,  SHANLEY, Jason, P. ,  KEMPF, Dale, J. ,  GRAMPOVNIK, David, J. ,  SUN, Ying ,  LIU, Dong ,  GAI, Yonghua ,  OR, Yat, Sun ,  WAGAW, Sable, H. ,  ENGSTROM, Ken ,  GRIEME, Tim ,  SHEIKH, Ahmad ,  MEI, Jianzhang

IPC: A61K38/12

CPC classification number: C07K1/113 ,  C07D487/04

Abstract: The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.

Abstract translation: 本发明涉及新的大环化合物及其使用方法。 本发明还涉及药物组合物，其包含本发明化合物或其药学上可接受的盐，酯或前药以及药学上可接受的载体或赋形剂。